Skip to content
FrontWave Imaging logo — Ultrasound breast imaging

FrontWave Imaging

Ultrasound breast imaging

Founded 2020 Spain Spain 10 employees Equity Crowdfunding Total: $750.00K Biotechnology, Medical Devices

General Information

Company Name FrontWave Imaging
Founded Year 2020
Location Spain Spain
Founders / Decision Makers
Team member Team member
Employees 10
Industries Biotechnology, Medical Devices
Funding Stage Equity Crowdfunding
Social

BounceWatch is an independent company data service, not affiliated with FrontWave Imaging. To contact FrontWave Imaging, visit frontwave.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does FrontWave Imaging compare?

A PDF of FrontWave Imaging and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting FrontWave Imaging soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About FrontWave Imaging

FrontWave Imaging is a biotechnology startup based in Spain, founded in 2020. The company specializes in ultrasound breast imaging for the diagnosis of breast cancer, utilizing supercomputing and ultrasound technology. Having received a significant €750.00K Equity Crowdfunding investment on 21 September 2021 from Capital Cell, a notable investor, FrontWave Imaging is making strides in the field of medical diagnosis. As a spin-off of Barcelona Supercomputing Center and Imperial College of London, in collaboration with 101 Ventures, the startup is leveraging cutting-edge technology to advance breast cancer diagnosis, positioning itself as a promising venture for potential investors.

Business keywords: Medical imaging, Breast cancer diagnosis, Ultrasound technology, Supercomputing, 3D imaging, Medical technology, Healthcare innovation, Medical diagnosis, Medical software, Startup, Biomedical imaging

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Equity Crowdfunding €750.00K 1
Capital Cell
21 Sep 2021

FrontWave Imaging Alternatives & Competitors

View All Alternatives
FrontWave Imaging vs

Delivering medical innovations to transform early detection of breast cancer and save women’s lives...

Growth
34 employees
Biotechnology, Health Care
FrontWave Imaging vs

Innovations in Ultrasound.

Post-IPO Equity
165 employees
Biotechnology, Health Care
FrontWave Imaging vs

Transforming the standard of care in breast cancer surgery.

42 employees
Biotechnology, Health Care

FAQ About FrontWave Imaging

Ultrasound breast imaging
FrontWave Imaging was founded in 2020.
FrontWave Imaging is headquartered in Spain.
FrontWave Imaging operates in Biotechnology and Medical Devices. Its work centres on Medical imaging, Breast cancer diagnosis, Ultrasound technology and Supercomputing.
FrontWave Imaging has approximately 10 employees.
FrontWave Imaging has completed 1 funding round, raising a total of $750.00K. The latest funding stage is Equity Crowdfunding.
Top alternatives and competitors to FrontWave Imaging include Delphinus Medical Technologies, Inc., SuperSonic Imagine, OncoRes Medical, Sigmascreening, Digistain®. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
FrontWave Imaging and Delphinus Medical Technologies, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for FrontWave Imaging, https://www.bouncewatch.com/company/frontwave-imaging, updated 11 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout